Centessa Pharmaceuticals PLC CNTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 06/11/21 EDT
21.71quote price arrow down-0.15 (-0.69%)
Volume
302,615
52 week range
20.00 - 25.82

...

Loading . . .
  • Open21.00
  • Day High22.26
  • Day Low20.40
  • Prev Close21.86
  • 52 Week High25.82
  • 52 Week High Date06/02/21
  • 52 Week Low20.00
  • 52 Week Low Date05/28/21

Key Stats

  • Market Cap1.865B
  • Shares Out85.92M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open21.00
  • Day High22.26
  • Day Low20.40
  • Prev Close21.86
  • 52 Week High25.82
  • 52 Week High Date06/02/21
  • 52 Week Low20.00
  • 52 Week Low Date05/28/21
  • Market Cap1.865B
  • Shares Out85.92M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-2.83
  • P/E (TTM)-7.68
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-246.655M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.10%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Centessa Pharmaceuticals PLC

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Centessa Pharmaceuticals Limited (Centessa) is a biopharmaceutical company. The Company is engaged in discovering, developing and delivering medicines to patients. The Company applies an asset-centric research and development (R&D) model to advance a portfolio of programs. Its portfolio consists of approximately 16 conviction programs, including four programs evaluated in clinical trials and 12 additional preclinical programs. Centessa's clinical stage product candidates...
Address
The Dorothy Hodgkin Building
Babraham Research Campus
Cambridge
CB22 3FH
United Kingdom